BioBanking - The Holy Grail of novel drug and diagnostic developments?

Por Marko-Varga, György
Publicado em 2011

BioBanking as the central tool for translational medicine CTM issue 2013

Por Marko-Varga, György
Publicado em 2013

Clinical protein science developments for patient monitoring in hospital central laboratories

Por Malm, Johan, Marko-Varga, György
Publicado no Clin Transl Med (2016)

Gestão de riscos no Brasil /

Por Duarte Junior, Antonio M., Varga, Gyorgy
Publicado em 2003

Gestão de investimentos e fundos /

Por Varga, Gyorgy, Leal, Ricardo Pereira Câmara
Publicado em 2006

Monitoring targeted drug delivery: a key cornerstone of precision medicine

Por Marko-Varga, György, Fehniger, Thomas E
Publicado em 2012

Building the basis for proteomics in personalized medicine for targeted treatment

Por Kwon, Ho Jeong, Fehniger, Thomas E., Marko-Varga, György
Publicado no Clin Transl Med (2016)

2DDB – a bioinformatics solution for analysis of quantitative proteomics data

Por Malmström, Lars, Marko-Varga, György, Westergren-Thorsson, Gunilla, Laurell, Thomas, Malmström, Johan
Publicado em 2006

Moving towards high density clinical signature studies with a human proteome catalogue developing multiplexing mass spectrometry assay panels

Por Rezeli, Melinda, Végvári, Ákos, Fehniger, Thomas E, Laurell, Thomas, Marko-Varga, György
Publicado em 2011

Biobank resources for future patient care: developments, principles and concepts

Por Végvári, Ákos, Welinder, Charlotte, Lindberg, Henrik, Fehniger, Thomas E, Marko-Varga, György
Publicado em 2011

Analytical Validation Considerations of Multiplex Mass-Spectrometry-Based Proteomic Platforms for Measuring Protein Biomarkers

Por Boja, Emily S., Fehniger, Thomas E., Baker, Mark S., Marko-Varga, György, Rodriguez, Henry
Publicado no J Proteome Res (2014)

Aplicação do método Black-Scholes ao mercado brasileiro de opções e compra ... /

Por Varga, Gyorgy, Werlang, Sergio Ribeiro da Costa, Escola de Pós-Graduação em Economia
Publicado em 1990

Localization of tamoxifen in human breast cancer tumors by MALDI mass spectrometry imaging

Por Végvári, Ákos, Shavkunov, Alexander S., Fehniger, Thomas E., Grabau, Dorthe, Niméus, Emma, Marko-Varga, György
Publicado no Clin Transl Med (2016)

Pathophysiology of Meningioma Growth in Pregnancy

Por Hortobágyi, Tibor, Bencze, János, Murnyák, Balázs, Kouhsari, Mahan C., Bognár, László, Marko-Varga, György
Publicado no Open Med (Wars) (2017)

Identification of Prostate Specific Antigen (PSA) Isoforms in Complex Biological Samples Utilizing Complementary Platforms

Por Végvári, Ákos, Rezeli, Melinda, Welinder, Charlotte, Malm, Johan, Lilja, Hans, Marko-Varga, György, Laurell, Thomas
Publicado em 2010

Cancer Phenotype Diagnosis and Drug Efficacy within Japanese Health Care

Por Nishimura, Toshihide, Kato, Harubumi, Ikeda, Norihiko, Kihara, Makoto, Nomura, Masaharu, Kato, Yasufumi, Marko-Varga, György
Publicado em 2012

Identification of a Novel Proteoform of Prostate Specific Antigen (SNP-L132I) in Clinical Samples by Multiple Reaction Monitoring

Por Végvári, Ákos, Sjödin, Karin, Rezeli, Melinda, Malm, Johan, Lilja, Hans, Laurell, Thomas, Marko-Varga, György
Publicado em 2013

The role of quantitative mass spectrometry in the discovery of pancreatic cancer biomarkers for translational science

Por Ansari, Daniel, Aronsson, Linus, Sasor, Agata, Welinder, Charlotte, Rezeli, Melinda, Marko-Varga, György, Andersson, Roland
Publicado em 2014

Porous Silicon Antibody Microarrays for Quantitative Analysis: Measurement of Free and Total PSA in Clinical Plasma Samples

Por Järås, Kerstin, Adler, Belinda, Tojo, Axel, Malm, Johan, Marko-Varga, György, Lilja, Hans, Laurell, Thomas
Publicado em 2012

Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma

Por Bauden, Monika, Kristl, Theresa, Sasor, Agata, Andersson, Bodil, Marko-Varga, György, Andersson, Roland, Ansari, Daniel
Publicado no BMC Cancer (2017)